KUALA LUMPUR: Cengild Medical Bhd's wholly-owned subsidiary Cengild Sdn Bhd has entered into a joint venture with Curie KL Sdn Bhd and OnCocare Holdings Sdn Bhd to establish oncology centres in the Klang Valley.
In a filing with Bursa Malaysia, Cengild said it will hold a 25% stake in the joint venture company, Curie Oncology KL Sdn Bhd, while Curie KL will own a majority 65% stake and OnCoCare, the remaining 10%.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
